Telogen Effluvium

  • Brandon Burroway
  • Jacob Griggs
  • Maria Abril Martinez-Velasco
  • Antonella TostiEmail author


Telogen effluvium represents one of the most common causes of hair loss. The treatment of telogen effluvium primarily relies on treating the underlying cause if it can be identified. Nutritional supplements are often prescribed even when there are no associated vitamin or oligoelement deficiencies. Education, reassurance, and shampooing are also very important steps.


Telogen effluvium Hair loss Hair shedding Hair pull Psychological impact Nutrition Minoxidil Education Reassurance 


  1. 1.
    Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol. 2002;27(5):389–5. Accessed 8 Oct 2018.PubMedCrossRefGoogle Scholar
  2. 2.
    Grover C, Khurana A. Telogen effluvium. Indian J Dermatol Venereol Leprol. 2013;79(5):591–603. Scholar
  3. 3.
    Nnoruka EN, Obiagboso I, Maduechesi C. Hair loss in children in South-East Nigeria: common and uncommon cases. Int J Dermatol. 2007;46(s1):18–22. Scholar
  4. 4.
    Al-Refu K. Hair loss in children: common and uncommon causes; clinical and epidemiological study in Jordan. Int J Trichology. 2013;5(4):185. Scholar
  5. 5.
    Whiting DA. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol. 1996;35(6):899–906. Accessed 8 Oct 2018.PubMedCrossRefGoogle Scholar
  6. 6.
    Trüeb RM. Telogen effluvium: is there a need for a new classification? Ski Appendage Disord. 2016;2(1–2):39–44. Scholar
  7. 7.
    Headington JT. Telogen effluvium. New concepts and review. Arch Dermatol. 1993;129(3):356–63. Accessed 8 Oct 2018.PubMedCrossRefGoogle Scholar
  8. 8.
    Malkud S. Telogen effluvium: a review. J Clin Diagn Res. 2015;9(9):WE01–3. Scholar
  9. 9.
    Rushton DH. Nutritional factors and hair loss. Clin Exp Dermatol. 2002;27(5):396–404. Accessed 8 Oct 2018.PubMedCrossRefGoogle Scholar
  10. 10.
    Goette DK, Odom RB. Alopecia in crash dieters. JAMA. 1976;235(24):2622–3. Accessed 9 Oct 2018.PubMedCrossRefGoogle Scholar
  11. 11.
    Yavuz IH, Yavuz GO, Bilgili SG, Demir H, Demir C. Assessment of heavy metal and trace element levels in patients with telogen effluvium. Indian J Dermatol. 2018;63(3):246–50. Scholar
  12. 12.
    Sinclair R. Diffuse hair loss. Int J Dermatol. 1999;38 Suppl 1:8–18. Accessed 9 Oct 2018PubMedCrossRefGoogle Scholar
  13. 13.
    Sperling LC, Sinclair RD, El Shabrawi-Caelen L. Dermatology 4th Edition Chapter 69. In: Bolognia JL, Schaffer JV, Cerroni L, editors. Dermatology. 4th ed. Philadelphia: Elsevier; 2017. p. 1168–71.Google Scholar
  14. 14.
    Loh S-H, Lew B-L, Sim W-Y. Localized telogen effluvium following hair transplantation. Ann Dermatol. 2018;30(2):214–7. Scholar
  15. 15.
    Tosti A, Piraccini BM, van Neste DJ. Telogen effluvium after allergic contact dermatitis of the scalp. Arch Dermatol. 2001;137(2):187–90. Accessed 10 Oct 2018.PubMedGoogle Scholar
  16. 16.
    Kim J-H, Lew B-L, Sim W-Y. Localized telogen effluvium after face lift surgery. Ann Dermatol. 2015;27(1):119–20. Scholar
  17. 17.
    Cassano N, Amerio P, D’Ovidio R, Vena GA. Hair disorders associated with autoimmune connective tissue diseases. G Ital Dermatol Venereol. 2014;149(5):555–65. Accessed 10 Oct 2018.PubMedGoogle Scholar
  18. 18.
    Bergfeld WF, Mulinari-Brenner F. Shedding: how to manage a common cause of hair loss. Cleve Clin J Med. 2001;68(3):256–61. Accessed 8 Oct 2018.PubMedCrossRefGoogle Scholar
  19. 19.
    Trüeb RM. Systematic approach to hair loss in women. J Dtsch Dermatol Ges. 2010;8(4):284–97, 284–298. Scholar
  20. 20.
    Cash TF, Price VH, Savin RC. Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol. 1993;29(4):568–75. Accessed 9 Oct 2018.PubMedCrossRefGoogle Scholar
  21. 21.
    Whiting DA. Chronic telogen effluvium. Dermatol Clin. 1996;14(4):723–31. Accessed 9 Oct 2018.PubMedCrossRefGoogle Scholar
  22. 22.
    Chen W, Yang C-C, Todorova A, Al Khuzaei S, Chiu HC, Worret WI, et al. Hair loss in elderly women. Eur J Dermatol. 2010;20(2):145–51. Scholar
  23. 23.
    Rebora A. Intermittent chronic telogen effluvium. Ski Appendage Disord. 2017;3(1):36–8. Scholar
  24. 24.
    Sinclair R. Chronic telogen effluvium: a study of 5 patients over 7 years. J Am Acad Dermatol. 2005;52(2 Suppl 1):12–6. Scholar
  25. 25.
    McDonald KA, Shelley AJ, Colantonio S, Beecker J. Hair pull test: evidence-based update and revision of guidelines. J Am Acad Dermatol. 2017;76(3):472–7. Scholar
  26. 26.
    Xu L, Liu KX, Senna MM. A practical approach to the diagnosis and management of hair loss in children and adolescents. Front Med. 2017;4:112. Scholar
  27. 27.
    Martínez-Velasco MA, Vázquez-Herrera NE, Maddy AJ, Asz-Sigall D, Tosti A. The hair shedding visual scale: a quick tool to assess hair loss in women. Dermatol Ther (Heidelb). 2017;7(1):155–65. Scholar
  28. 28.
    Sinclair R. Hair shedding in women: how much is too much? Br J Dermatol. 2015;173(3):846–8. Scholar
  29. 29.
    Kivanç-Altunay I, Savaş C, Gökdemir G, Köşlü A, Ayaydin EB. The presence of trichodynia in patients with telogen effluvium and androgenetic alopecia. Int J Dermatol. 2003;42(9):691–3. Accessed 10 Oct 2018.PubMedCrossRefGoogle Scholar
  30. 30.
    Bergfeld W. Telogen effluvium. In: Hordinsky M, Ofori AO, editors. UpToDate. Waltham, MA: UpToDate. Accessed on 13 Oct 2018.Google Scholar
  31. 31.
    Miteva M, Tosti A. Hair and scalp dermatoscopy. J Am Acad Dermatol. 2012;67(5):1040–8. Scholar
  32. 32.
    Harth W, Hermes B, Niemeier V, Gieler U. Clinical pictures and classification of somatoform disorders in dermatology. Eur J Dermatol. 2006;16(6):607–14. Accessed 9 Oct 2018.PubMedGoogle Scholar
  33. 33.
    Valdés F. Vitamin C. Actas Dermosifiliogr. 2006;97(9):557–68. Accessed 25 Nov 2018.PubMedCrossRefGoogle Scholar
  34. 34.
    Sant’Anna Addor FA, Donato LC, Melo CSA. Comparative evaluation between two nutritional supplements in the improvement of telogen effluvium. Clin Cosmet Investig Dermatol. 2018;11:431–6. Scholar
  35. 35.
    Ablon G. A 3-month, randomized, double-blind, placebo-controlled study evaluating the ability of an extra-strength marine protein supplement to promote hair growth and decrease shedding in women with self-perceived thinning hair. Dermatol Res Pract. 2015;2015:841570. Scholar
  36. 36.
    Viviscal. Viviscal extra strength. Accessed 21 Nov 2018.
  37. 37.
    Ablon G, Kogan S. A six-month, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of a nutraceutical supplement for promoting hair growth in women with self-perceived thinning hair. J Drugs Dermatol. 2018;17(5):558–65. Accessed 21 Nov 2018.PubMedGoogle Scholar
  38. 38.
    Bergner T. Diffuse effluvium, damage to hair structure, and disturbances of nail growth treated successfully. Dt Derm. 1999;47:881–4. Accessed 21 Nov 2018.Google Scholar
  39. 39.
    Le Floc’h C, Cheniti A, Connétable S, Piccardi N, Vincenzi C, Tosti A. Effect of a nutritional supplement on hair loss in women. J Cosmet Dermatol. 2015;14(1):76–82. Scholar
  40. 40.
    Nichols AJ, Hughes OB, Canazza A, Zaiac MN. An open-label evaluator blinded study of the efficacy and safety of a new nutritional supplement in androgenetic alopecia: a pilot study. J Clin Aesthet Dermatol. 2017;10(2):52–6. Accessed 12 Jan 2019.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol. 2004;123(3):455–7. Scholar
  42. 42.
    Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150(2):186–94. Accessed 13 Oct 2018.PubMedCrossRefGoogle Scholar
  43. 43.
    The Transfer of Drugs and Other Chemicals Into Human Milk. located on the World Wide Web at: AMERICAN ACADEMY OF PEDIATRICS The Transfer of Drugs and Other Chemicals Into Human Milk. 2001. Accessed 25 Nov 2018.
  44. 44.
    Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges. 2011;9(Suppl 6):S1–57. Scholar
  45. 45.
    Garg S, Manchanda S. Platelet-rich plasma-an “Elixir” for treatment of alopecia: personal experience on 117 patients with review of literature. Stem Cell Investig. 2017;4:64. Scholar
  46. 46.
    Jimenez JJ, Wikramanayake TC, Bergfeld W, Hordinsky M, Hickman JG, Hamblin MR, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol. 2014;15(2):115–27. Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Brandon Burroway
    • 1
  • Jacob Griggs
    • 1
  • Maria Abril Martinez-Velasco
    • 2
  • Antonella Tosti
    • 3
    Email author
  1. 1.Dr. Phillip Frost Department of Dermatology and Cutaneous SurgeryUniversity of Miami, Leonard M. Miller School of MedicineMiamiUSA
  2. 2.National University of Mexico, Department of Onco-dermatology and Trichology ClinicMexico CityMexico
  3. 3.Fredric Brandt Endowed Professor of Dermatology, Dr. Phillip Frost Department of Dermatology and Cutaneous SurgeryUniversity of Miami Miller School of MedicineMiamiUSA

Personalised recommendations